{
  "data": {
    "type": "relative_risk",
    "data": [
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z41.0",
        "predisposition": "Z41.0*  - TRANSPLANT MARROW BONE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 5.46,
        "risk_count": 811,
        "predisposition_and_risk": 38,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 201108,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z41.0",
        "predisposition": "Z41.0*  - TRANSPLANT MARROW BONE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 4.62,
        "risk_count": 867,
        "predisposition_and_risk": 28,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 202729,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_725",
        "predisposition": "725* POLYMYALGIA RHEUMATICA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 2.68,
        "risk_count": 867,
        "predisposition_and_risk": 57,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 712633,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_277.3",
        "predisposition": "277.3* AMYLOIDOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 2.48,
        "risk_count": 811,
        "predisposition_and_risk": 41,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 478008,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_277.3",
        "predisposition": "277.3* AMYLOIDOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 2.42,
        "risk_count": 867,
        "predisposition_and_risk": 42,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 581636,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_289.8",
        "predisposition": "289.8* OTHER SPECIFIED DISEASES OF BLOOD AND BLOOD-FORMING ORGANS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 2.23,
        "risk_count": 867,
        "predisposition_and_risk": 21,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 315277,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.3",
        "predisposition": "Z88.3* OTHER X-RAY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 2.1,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 382770,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V67.0",
        "predisposition": "V67.0* FOLLOW-UP EXAMINATION FOLLOWING SURGERY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.86,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 430888,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_805_",
        "predisposition": "805 # OF VERTEBRAL COLUMN WITHOUT SPINAL CORD INJURY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.86,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 498580,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_287.5",
        "predisposition": "287.5* THROMBOCYTOPENIA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.85,
        "risk_count": 811,
        "predisposition_and_risk": 28,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 436905,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_373.3",
        "predisposition": "373.3* NONINFECTIOUS DERMATOSES OF EYELID",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.84,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 454091,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_309.0",
        "predisposition": "309.0* ADJUSTMENT REACTION WITH BRIEF DEPRESSIVE REACTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.82,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 460098,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_444.2",
        "predisposition": "444.2* EMBOLISM AND THROMBOSIS OF ARTERIES OF THE EXTREMITIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.82,
        "risk_count": 811,
        "predisposition_and_risk": 24,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 380638,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.5",
        "predisposition": "785.5* SHOCK WITHOUT MENTION OF TRAUMA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.8,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 514202,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_369.1",
        "predisposition": "369.1* BETTER EYE:MODER./SEVERE IMPAIRM.,LESSER EYE;PROFOND IMPAIRM.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.79,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 339118,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_244_",
        "predisposition": "244 ACQUIRED HYPOTHYROIDISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.79,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 485981,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_710.2",
        "predisposition": "710.2* SICCA SYNDROME",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.76,
        "risk_count": 867,
        "predisposition_and_risk": 50,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 948089,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_703.8",
        "predisposition": "703.8* OTHER SPECIFIED DISEASES OF NAIL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.73,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 351127,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z79.3",
        "predisposition": "Z79.3* OPEN REDUCTION OF FRACTURE WITH INTERNAL FIXATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.73,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 426390,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_789.1",
        "predisposition": "789.1* HEPATOMEGALY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.72,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 485184,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_9",
        "predisposition": "9* HYPERTENSION ROUTINE FOLLOW UP",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.68,
        "risk_count": 811,
        "predisposition_and_risk": 31,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 535151,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_458.9",
        "predisposition": "458.9* HYPOTENSION, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.65,
        "risk_count": 811,
        "predisposition_and_risk": 29,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 508826,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_730.0",
        "predisposition": "730.0* ACUTE OSTEOMYELITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.63,
        "risk_count": 811,
        "predisposition_and_risk": 41,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 725804,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_172.9",
        "predisposition": "172.9* MELANOMA OF SKIN, SITE UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.6,
        "risk_count": 867,
        "predisposition_and_risk": 44,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 919212,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A28",
        "predisposition": "A28* DISABILITY/IMPAIRMENT NOS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.59,
        "risk_count": 867,
        "predisposition_and_risk": 36,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 755102,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_372.5",
        "predisposition": "372.5* CONJUNCTIVAL DEGENERATIONS AND DEPOSITS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.58,
        "risk_count": 811,
        "predisposition_and_risk": 25,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 458547,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.3",
        "predisposition": "780.3* CONVULSIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.58,
        "risk_count": 867,
        "predisposition_and_risk": 31,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 658083,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V58.1",
        "predisposition": "V58.1* MAINTENANCE CHEMOTHERAPY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.58,
        "risk_count": 811,
        "predisposition_and_risk": 51,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 935404,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z38.9",
        "predisposition": "Z38.9* PUNCTURE OF VESSEL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.58,
        "risk_count": 867,
        "predisposition_and_risk": 21,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 445184,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790_",
        "predisposition": "790 NONSPECIFIC FINDINGS ON EXAMINATION OF BLOOD",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.58,
        "risk_count": 867,
        "predisposition_and_risk": 53,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1120516,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V67.5",
        "predisposition": "V67.5* FOLLOW-UP EXAMINATION FOLLOWING OTHER TREATMENT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.57,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 533470,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V87.4",
        "predisposition": "V87.4* PERSONAL HISTORY OF DRUG THERAPY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.56,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 471379,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_288.0",
        "predisposition": "288.0* AGRANULOCYTOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.55,
        "risk_count": 811,
        "predisposition_and_risk": 39,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 727622,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_273.8",
        "predisposition": "273.8* OTHER DISORDERS OF PLASMA PROTEIN METABOLISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.54,
        "risk_count": 867,
        "predisposition_and_risk": 28,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 607380,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_361.0",
        "predisposition": "361.0* RETINAL DETACHMENT WITH RETINAL DEFECT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.54,
        "risk_count": 811,
        "predisposition_and_risk": 29,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 544446,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_721.1",
        "predisposition": "721.1* CERVICAL SPONDYLOSIS WITH MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.54,
        "risk_count": 811,
        "predisposition_and_risk": 33,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 619752,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_918.1",
        "predisposition": "918.1* SUPERFICIAL INJURY OF CORNEA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.54,
        "risk_count": 867,
        "predisposition_and_risk": 28,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 608630,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_715.0",
        "predisposition": "715.0* OSTEOARTHROSIS, GENERALIZED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.53,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 433655,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_R75",
        "predisposition": "R75* SINUSITIS ACUTE/CHRON.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.53,
        "risk_count": 867,
        "predisposition_and_risk": 42,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 919982,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_601.1",
        "predisposition": "601.1* CHRONIC PROSTATITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.52,
        "risk_count": 811,
        "predisposition_and_risk": 24,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 456417,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z93.8",
        "predisposition": "Z93.8* OTHER REHABILITATION THERAPY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.52,
        "risk_count": 811,
        "predisposition_and_risk": 39,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 742888,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_728.6",
        "predisposition": "728.6* CONTRACTURE OF PALMAR FASCIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.51,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 401234,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z96.7",
        "predisposition": "Z96.7* OTHER CONTINUOUS MECHANICAL VENTILATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.51,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 554757,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_441_",
        "predisposition": "441 AORTIC ANEURYSM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.51,
        "risk_count": 811,
        "predisposition_and_risk": 33,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 633760,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_584_",
        "predisposition": "584 ACUTE RENAL FAILURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.51,
        "risk_count": 867,
        "predisposition_and_risk": 55,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1219398,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_535.6",
        "predisposition": "535.6* __DUODENITIS____1992",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.5,
        "risk_count": 811,
        "predisposition_and_risk": 29,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 557618,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_428.0",
        "predisposition": "428.0* CONGESTIVE HEART FAILURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.49,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 492471,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_333.1",
        "predisposition": "333.1* ESSENTIAL AND OTHER SPECIFIED FORMS OF TREMOR",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.47,
        "risk_count": 867,
        "predisposition_and_risk": 33,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 748914,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_447.6",
        "predisposition": "447.6* ARTERITIS, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.47,
        "risk_count": 867,
        "predisposition_and_risk": 21,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 476488,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_738.4",
        "predisposition": "738.4* ACQUIRED SPONDYLOLISTHESIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.47,
        "risk_count": 867,
        "predisposition_and_risk": 41,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 932427,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_728.2",
        "predisposition": "728.2* MUSCULAR WASTING AND DISUSE ATROPHY, NOT ELSEWHERE CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.46,
        "risk_count": 867,
        "predisposition_and_risk": 23,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 528610,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_824.2",
        "predisposition": "824.2* FRACTURE OF LATERAL MALLEOLUS, CLOSED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.46,
        "risk_count": 867,
        "predisposition_and_risk": 32,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 733499,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_590.1",
        "predisposition": "590.1* ACUTE PYELONEPHRITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.45,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 507083,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_438_",
        "predisposition": "438 LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.45,
        "risk_count": 867,
        "predisposition_and_risk": 23,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 530601,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_424.2",
        "predisposition": "424.2* TRICUSPID VALVE DISORDERS, SPECIFIED AS NONRHEUMATIC",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.44,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 558100,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V15.0",
        "predisposition": "V15.0* PERSONAL HISTORY OF ALLERGY,OTHER THAN TO MEDICINAL AGENTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.44,
        "risk_count": 811,
        "predisposition_and_risk": 36,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 723633,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V43.1",
        "predisposition": "V43.1* LENS REPLACED BY OTHER MEANS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.44,
        "risk_count": 867,
        "predisposition_and_risk": 47,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1091835,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V49.8",
        "predisposition": "V49.8* OTHER SPECIFIED PROBLEMS INFLUENCING HEALTH STATUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.44,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 423053,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z39.2",
        "predisposition": "Z39.2* OTHER SHUNT OR VASCULAR BYPASS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.44,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 580629,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_054.9",
        "predisposition": "054.9* HERPES SIMPLEX WITHOUT MENTION OF COMPLICATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.43,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 464691,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_364.3",
        "predisposition": "364.3* UNSPECIFIED IRIDOCYCLITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.43,
        "risk_count": 811,
        "predisposition_and_risk": 22,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 445968,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_373.1",
        "predisposition": "373.1* HORDEOLUM AND OTHER DEEP INFLAMMATION OF EYELID",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.43,
        "risk_count": 867,
        "predisposition_and_risk": 42,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 985747,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_527.2",
        "predisposition": "527.2* SIALOADENITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.43,
        "risk_count": 867,
        "predisposition_and_risk": 27,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 632856,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_9",
        "predisposition": "9* HYPERTENSION ROUTINE FOLLOW UP",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.43,
        "risk_count": 867,
        "predisposition_and_risk": 28,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 654633,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_332.0",
        "predisposition": "332.0* PARALYSIS AGITANS, PARKINSON'S DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.42,
        "risk_count": 867,
        "predisposition_and_risk": 67,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1582763,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_726.0",
        "predisposition": "726.0* ADHESIVE CAPSULITIS OF SHOULDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.42,
        "risk_count": 811,
        "predisposition_and_risk": 26,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 528860,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.6",
        "predisposition": "780.6* PYREXIA (OF UNKNOWN ORIGIN)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.42,
        "risk_count": 811,
        "predisposition_and_risk": 92,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1867068,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_N17",
        "predisposition": "N17* VERTIGO/DIZZINESS (EXCL.H82)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.42,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 517088,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_275.4",
        "predisposition": "275.4* DISORDERS OF CALCIUM METABOLISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.41,
        "risk_count": 867,
        "predisposition_and_risk": 76,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1806146,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_506.1",
        "predisposition": "506.1* ACUTE PULMONARY EDEMA DUE TO FUMES AND VAPORS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.41,
        "risk_count": 867,
        "predisposition_and_risk": 36,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 853162,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_438.8",
        "predisposition": "438.8* OTHER LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.4,
        "risk_count": 867,
        "predisposition_and_risk": 23,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 548235,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_682.6",
        "predisposition": "682.6* CELLULITIS AND ABSCESS OF LEG, EXCEPT FOOT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.4,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 526205,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_701.1",
        "predisposition": "701.1* KERATODERMA, ACQUIRED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.4,
        "risk_count": 867,
        "predisposition_and_risk": 46,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1098451,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_228.0",
        "predisposition": "228.0* HEMANGIOMA, ANY SITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 811,
        "predisposition_and_risk": 40,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 832372,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.8",
        "predisposition": "362.8* OTHER RETINAL DISORDERS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 579247,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_414.0",
        "predisposition": "414.0* CORONARY ATHEROSCLEROSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 867,
        "predisposition_and_risk": 104,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2495699,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_454.3",
        "predisposition": "454.3* VARICOSE VEINS SEVERE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 867,
        "predisposition_and_risk": 35,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 844964,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_511.9",
        "predisposition": "511.9* UNSPECIFIED PLEURAL EFFUSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 811,
        "predisposition_and_risk": 56,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1161955,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_524.6",
        "predisposition": "524.6* TEMPOROMANDIBULAR JOINT DISORDERS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 811,
        "predisposition_and_risk": 40,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 833363,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_700.9",
        "predisposition": "700.9* CLAVUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 867,
        "predisposition_and_risk": 40,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 965217,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_922.3",
        "predisposition": "922.3* CONTUSION OF BACK",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 867,
        "predisposition_and_risk": 74,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1778111,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_135_",
        "predisposition": "135 SARCOIDOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.39,
        "risk_count": 811,
        "predisposition_and_risk": 22,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 457511,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_518.8",
        "predisposition": "518.8* OTHER DISEASES OF LUNG, NOT ELSEWHERE CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.38,
        "risk_count": 867,
        "predisposition_and_risk": 40,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 966531,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_692.8",
        "predisposition": "692.8* CONTACT DERMATITIS + ECZEMA DUE TO OTHER SPECIFIED AGENTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.38,
        "risk_count": 867,
        "predisposition_and_risk": 21,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 508540,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_705.8",
        "predisposition": "705.8* OTHER SPECIFIED DISORDERS OF SWEAT GLANDS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.38,
        "risk_count": 811,
        "predisposition_and_risk": 22,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 462254,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V43.3",
        "predisposition": "V43.3* HEART VALVE REPLACED BY OTHER MEANS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.38,
        "risk_count": 867,
        "predisposition_and_risk": 29,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 702678,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V58.1",
        "predisposition": "V58.1* MAINTENANCE CHEMOTHERAPY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.38,
        "risk_count": 867,
        "predisposition_and_risk": 42,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1020468,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_288.8",
        "predisposition": "288.8* OTHER SPECIFIED DISEASE OF WHITE BLOOD CELLS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.37,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 634567,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_333.1",
        "predisposition": "333.1* ESSENTIAL AND OTHER SPECIFIED FORMS OF TREMOR",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.37,
        "risk_count": 811,
        "predisposition_and_risk": 28,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 590398,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_620.0",
        "predisposition": "620.0* FOLLICULAR CYST OF OVARY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.37,
        "risk_count": 867,
        "predisposition_and_risk": 50,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1219048,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.6",
        "predisposition": "780.6* PYREXIA (OF UNKNOWN ORIGIN)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.37,
        "risk_count": 867,
        "predisposition_and_risk": 68,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1665527,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_789.2",
        "predisposition": "789.2* SPLENOMEGALY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.37,
        "risk_count": 811,
        "predisposition_and_risk": 33,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 697234,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z89.1",
        "predisposition": "Z89.1* ANATOM-PHYSIOL.MEASUREMENTS/MANUAL EXAMIN.-NERVOUS SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.37,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 611250,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_556_",
        "predisposition": "556 IDIOPATHIC PROCTOCOLITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.37,
        "risk_count": 867,
        "predisposition_and_risk": 31,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 757685,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_3",
        "predisposition": "3* AFTERCARE CHECK-UP NO DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.37,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 538388,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_280.1",
        "predisposition": "280.1* IRON DEF.ANEMIA SECONDARY TO INADEQUATE DIETARY IRON INTAKE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 867,
        "predisposition_and_risk": 70,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1723159,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_357.2",
        "predisposition": "357.2* POLYNEUROPATHY IN DIABETES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 867,
        "predisposition_and_risk": 33,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 810618,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_367.2",
        "predisposition": "367.2* ASTIGMATISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 867,
        "predisposition_and_risk": 56,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1382243,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_440.2",
        "predisposition": "440.2* ATHEROSCLEROSIS OF ARTERIES OF THE EXTREMITIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 811,
        "predisposition_and_risk": 36,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 766610,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_577.0",
        "predisposition": "577.0* ACUTE PANCREATITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 613564,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_958.3",
        "predisposition": "958.3* POSTTRAUMATIC WOUND INFECTION NOT ELSEWHERE CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 867,
        "predisposition_and_risk": 80,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1968765,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z13.4",
        "predisposition": "Z13.4* EXTRACAPS.EXTRACT.OF LENS BY FRAGMENT.AND ASPIRATION TECHN.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 811,
        "predisposition_and_risk": 105,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2237018,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z37.9",
        "predisposition": "Z37.9* OTHER OPERATIONS ON HEART AND PERICARDIUM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 487628,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z60.6",
        "predisposition": "Z60.6* OTHER PROSTATECTOMY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 811,
        "predisposition_and_risk": 31,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 656862,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z99.0",
        "predisposition": "Z99.0* TRANSFUSION OF BLOOD AND BLOOD COMPONENTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 811,
        "predisposition_and_risk": 67,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1422055,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L92",
        "predisposition": "L92* SHOULDER SYNDROME",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 681718,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_P74",
        "predisposition": "P74* ANXIETY DISORDER/ANXIETY STATE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.36,
        "risk_count": 811,
        "predisposition_and_risk": 25,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 531949,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_369.0",
        "predisposition": "369.0* PROFOUND VISION IMPAIRMENT, BOTH EYES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.35,
        "risk_count": 867,
        "predisposition_and_risk": 23,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 568979,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z60.2",
        "predisposition": "Z60.2* TRANSURETHRAL PROSTATECTOMY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.35,
        "risk_count": 811,
        "predisposition_and_risk": 22,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 472624,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z81.4",
        "predisposition": "Z81.4* ARTHROPLASTY OF KNEE AND ANKLE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.35,
        "risk_count": 867,
        "predisposition_and_risk": 82,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2034109,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_356_",
        "predisposition": "356 HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.35,
        "risk_count": 867,
        "predisposition_and_risk": 132,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3270683,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_285.2",
        "predisposition": "285.2* ANEMIA IN CHRONIC ILLNESS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.34,
        "risk_count": 867,
        "predisposition_and_risk": 53,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1319529,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.5",
        "predisposition": "362.5* DEGENERATION OF MACULA AND POSTERIOR POLE OF RETINA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.34,
        "risk_count": 867,
        "predisposition_and_risk": 111,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2773616,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_276.8",
        "predisposition": "276.8* HYPOPOTASSEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 867,
        "predisposition_and_risk": 30,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 754094,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_287.2",
        "predisposition": "287.2* OTHER NONTHROMBOCYTOPENIC PURPURAS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 867,
        "predisposition_and_risk": 47,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1181679,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_397.0",
        "predisposition": "397.0* DISEASES OF TRICUSPID VALVE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 811,
        "predisposition_and_risk": 24,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 523579,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_428.3",
        "predisposition": "428.3* DIASTOLIC HEART FAILURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 499458,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_429.3",
        "predisposition": "429.3* CARDIOMEGALY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 811,
        "predisposition_and_risk": 33,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 717453,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_451.1",
        "predisposition": "451.1* PHLEBITIS AND THROMBOPHLEBITIS,DEEP VESSELS LOWER EXTREMITIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 867,
        "predisposition_and_risk": 65,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1640887,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_722.7",
        "predisposition": "722.7* INTERVERTEBRAL DISC DISORDER WITH MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 603664,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.6",
        "predisposition": "785.6* ENLARGEMENT OF LYMPH NODES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 811,
        "predisposition_and_risk": 66,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1437496,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z87.0",
        "predisposition": "Z87.0* SOFT TISSUE X-RAY OF FACE, HEAD, AND NECK",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.33,
        "risk_count": 811,
        "predisposition_and_risk": 73,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1581491,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_110.3",
        "predisposition": "110.3* DERMATOPHYTOSIS OF GROIN AND PERIANAL AREA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.32,
        "risk_count": 867,
        "predisposition_and_risk": 27,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 686449,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_374.3",
        "predisposition": "374.3* PTOSIS OF EYELID",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.32,
        "risk_count": 867,
        "predisposition_and_risk": 69,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1742740,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_696.1",
        "predisposition": "696.1* OTHER PSORIASIS AND SIMILAR DISORDERS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.32,
        "risk_count": 867,
        "predisposition_and_risk": 53,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1343276,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.9",
        "predisposition": "780.9* OTHER GENERAL SYMPTOMS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.32,
        "risk_count": 811,
        "predisposition_and_risk": 86,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1886447,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_918.1",
        "predisposition": "918.1* SUPERFICIAL INJURY OF CORNEA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.32,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 655753,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_949.2",
        "predisposition": "949.2* BLISTERS WITH EPIDERMAL LOSS,BURN 2ND.DEG.UNSPECIFIED SITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.32,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 635685,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z99.0",
        "predisposition": "Z99.0* TRANSFUSION OF BLOOD AND BLOOD COMPONENTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.32,
        "risk_count": 867,
        "predisposition_and_risk": 55,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1396584,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_A28",
        "predisposition": "A28* DISABILITY/IMPAIRMENT NOS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.32,
        "risk_count": 811,
        "predisposition_and_risk": 28,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 613379,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_276.5",
        "predisposition": "276.5* VOLUME DEPLETION DISORDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.31,
        "risk_count": 867,
        "predisposition_and_risk": 33,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 845745,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_351.0",
        "predisposition": "351.0* BELL'S PALSY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.31,
        "risk_count": 811,
        "predisposition_and_risk": 51,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1122931,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V02.6",
        "predisposition": "V02.6* CARRIER OR SUSPECTED CARRIER OF VIRAL HEPATITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.31,
        "risk_count": 811,
        "predisposition_and_risk": 37,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 814648,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V46.2",
        "predisposition": "V46.2* DEPENDENCE ON SUPPLEMENTAL OXYGEN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.31,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 611671,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_386_",
        "predisposition": "386 VERTIGINOUS SYNDROMES AND OTHER DISORDERS OF VESTIBULAR SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.31,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 461889,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_410_",
        "predisposition": "410 ACUTE MYOCARDIAL INFARCTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.31,
        "risk_count": 867,
        "predisposition_and_risk": 72,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1844083,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_435_",
        "predisposition": "435 TRANSIENT CEREBRAL ISCHEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.31,
        "risk_count": 811,
        "predisposition_and_risk": 73,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1605650,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_A05",
        "predisposition": "A05* GENERAL DETERIORATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.31,
        "risk_count": 811,
        "predisposition_and_risk": 49,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1078790,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_379.9",
        "predisposition": "379.9* UNSPECIFIED DISORDER OF EYE AND ADNEXA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 867,
        "predisposition_and_risk": 34,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 875049,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_727.5",
        "predisposition": "727.5* RUPTURE OF SYNOVIUM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 867,
        "predisposition_and_risk": 30,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 774528,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_787.1",
        "predisposition": "787.1* HEARTBURN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 811,
        "predisposition_and_risk": 53,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1176062,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z54.9",
        "predisposition": "Z54.9* OTHER OPERATIONS OF ABDOMINAL REGION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 811,
        "predisposition_and_risk": 25,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 556459,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z93.3",
        "predisposition": "Z93.3* OTHER PHYSICAL THERAPY THERAPEUTIC PROCEDURES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 465902,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_825_",
        "predisposition": "825 FRACTURE OF ONE OR MORE TARSAL AND METATARSAL BONES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 867,
        "predisposition_and_risk": 21,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 542194,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_185",
        "predisposition": "185* MALIGNANT NEOPLASM OF PROSTATE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 811,
        "predisposition_and_risk": 93,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2061260,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_591",
        "predisposition": "591* HYDRONEPHROSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 867,
        "predisposition_and_risk": 39,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1006051,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_S02",
        "predisposition": "S02* PRURITUS; SKIN ITCHING",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.3,
        "risk_count": 811,
        "predisposition_and_risk": 44,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 976695,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_435.9",
        "predisposition": "435.9* UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 670365,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_690.1",
        "predisposition": "690.1* SEBORRHEIC DERMATITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 867,
        "predisposition_and_risk": 61,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1579370,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_702.9",
        "predisposition": "702.9* ACTINIC KERATOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 867,
        "predisposition_and_risk": 26,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 673588,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_E88.8",
        "predisposition": "E88.8* OTHER AND UNSPECIFIED ACCIDENTAL FALL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 811,
        "predisposition_and_risk": 118,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2645979,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z44.1",
        "predisposition": "Z44.1* DIAGNOSTIC PROCEDURES ON STOMACH",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 811,
        "predisposition_and_risk": 22,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 492702,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z88.0",
        "predisposition": "Z88.0* SOFT TISSUE X-RAY OF ABDOMEN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 717839,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_581_",
        "predisposition": "581 NEPHROTIC SYNDROME",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 867,
        "predisposition_and_risk": 26,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 674192,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_682_",
        "predisposition": "682 OTHER CELLULITIS AND ABSCESS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 572305,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A05",
        "predisposition": "A05* GENERAL DETERIORATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.29,
        "risk_count": 867,
        "predisposition_and_risk": 43,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1115556,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_366.5",
        "predisposition": "366.5* AFTER-CATARACT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 811,
        "predisposition_and_risk": 42,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 948230,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_366.5",
        "predisposition": "366.5* AFTER-CATARACT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 867,
        "predisposition_and_risk": 42,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1100191,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_368.8",
        "predisposition": "368.8* OTHER SPECIFIED VISUAL DISTURBANCES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 867,
        "predisposition_and_risk": 63,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1651037,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_374.0",
        "predisposition": "374.0* ENTROPION AND TRICHIASIS OF EYELID",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 867,
        "predisposition_and_risk": 21,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 550733,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_518.8",
        "predisposition": "518.8* OTHER DISEASES OF LUNG, NOT ELSEWHERE CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 811,
        "predisposition_and_risk": 48,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1080674,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_726.5",
        "predisposition": "726.5* ENTHESOPATHY OF HIP REGION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 811,
        "predisposition_and_risk": 29,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 655164,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_782.2",
        "predisposition": "782.2* LOCALIZED SUPERFICIAL SWELLING, MASS, OR LUMP",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 721859,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V14.1",
        "predisposition": "V14.1* PERSONAL HISTORY OF ALLERGY TO OTHER ANTIBIOTIC AGENT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 867,
        "predisposition_and_risk": 43,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1124233,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z95.4",
        "predisposition": "Z95.4* NONOPERATIVE PROCEDURES RELATED TO HEARING",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 811,
        "predisposition_and_risk": 35,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 789640,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_585_",
        "predisposition": "585 CHRONIC RENAL FAILURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 867,
        "predisposition_and_risk": 28,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 733378,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_692_",
        "predisposition": "692 CONTACT DERMATITIS AND OTHER ECZEMA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 811,
        "predisposition_and_risk": 79,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1789835,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_W72",
        "predisposition": "W72* MALIGNANT NEOPLASM **",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.28,
        "risk_count": 811,
        "predisposition_and_risk": 24,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 543549,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_288.8",
        "predisposition": "288.8* OTHER SPECIFIED DISEASE OF WHITE BLOOD CELLS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 581025,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_327.2",
        "predisposition": "327.2* ORGANIC SLEEP APNEA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 728097,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_371.0",
        "predisposition": "371.0* CORNEAL SCARS AND OPACITIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 867,
        "predisposition_and_risk": 21,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 554427,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_535.4",
        "predisposition": "535.4* __GASTRITIS____1992 SPECIFIED OTHER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 811,
        "predisposition_and_risk": 48,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1092679,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_575.0",
        "predisposition": "575.0* ACUTE CHOLECYSTITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 660712,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_584.9",
        "predisposition": "584.9* ACUTE RENAL FAILURE, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 811,
        "predisposition_and_risk": 94,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2137676,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_593.2",
        "predisposition": "593.2* CYST OF KIDNEY, ACQUIRED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 631973,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_697.0",
        "predisposition": "697.0* LICHEN PLANUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 579775,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V12.5",
        "predisposition": "V12.5* PERSONAL HISTORY OF DISEASES OF CIRCULATORY SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 811,
        "predisposition_and_risk": 97,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2212473,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V43.3",
        "predisposition": "V43.3* HEART VALVE REPLACED BY OTHER MEANS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.27,
        "risk_count": 811,
        "predisposition_and_risk": 34,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 771588,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_375.2",
        "predisposition": "375.2* EPIPHORA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.26,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 528341,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_714.9",
        "predisposition": "714.9* UNSPECIFIED INFLAMMATORY POLYARTHROPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.26,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 638012,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z36.1",
        "predisposition": "Z36.1* BYPASS ANASTOMOSIS FOR HEART REVASCULARIZATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.26,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 688767,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_356_",
        "predisposition": "356 HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.26,
        "risk_count": 811,
        "predisposition_and_risk": 144,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3294952,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_438_",
        "predisposition": "438 LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.26,
        "risk_count": 811,
        "predisposition_and_risk": 37,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 849905,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_T93",
        "predisposition": "T93* LIPID METABOLISM DISORDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.26,
        "risk_count": 867,
        "predisposition_and_risk": 86,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2276397,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_244.9",
        "predisposition": "244.9* UNSPECIFIED ACQUIRED HYPOTHYROIDISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 811,
        "predisposition_and_risk": 43,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 997322,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_250.4",
        "predisposition": "250.4* DIABETES WITH RENAL MANIFESTATIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 530886,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_411.8",
        "predisposition": "411.8* OTHER ACUTE AND SUBACUTE FORMS OF ISCHEMIC HEART DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 811,
        "predisposition_and_risk": 26,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 602273,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.8",
        "predisposition": "427.8* OTHER SPECIFIED CARDIAC DYSRHYTHMIAS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 867,
        "predisposition_and_risk": 83,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2227713,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_553.2",
        "predisposition": "553.2* VENTRAL HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 811,
        "predisposition_and_risk": 54,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1254128,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_995.3",
        "predisposition": "995.3* ALLERGY, UNSPECIFIED, NOT ELSEWHERE CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 811,
        "predisposition_and_risk": 56,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1291907,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P91.1",
        "predisposition": "P91.1* PERSONAL HISTORY OF NONCOMPLIANCE WITH MEDICAL TREAT REGIMEN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 867,
        "predisposition_and_risk": 23,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 616237,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z99.2",
        "predisposition": "Z99.2* INJECT.OR INFUSION OF OTHER THERAPEUTIC OR PROPHYLACTIC SUBS.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 811,
        "predisposition_and_risk": 120,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2777420,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L14",
        "predisposition": "L14* LEG/THIGH SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 811,
        "predisposition_and_risk": 105,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2426792,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L89",
        "predisposition": "L89* OSTEOARTHRITIS OF HIP",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.25,
        "risk_count": 867,
        "predisposition_and_risk": 28,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 749200,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_396.3",
        "predisposition": "396.3* MITRAL VALVE INSUFFICIENCY AND AORTIC VALVE INSUFFICIENCY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.24,
        "risk_count": 867,
        "predisposition_and_risk": 27,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 726736,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_807.0",
        "predisposition": "807.0* CLOSED FRACTURE OF RIB(S)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.24,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 490366,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_999.9",
        "predisposition": "999.9* UNSPECIFIED COMPLICATIONS OF MEDICAL CARE,NOT ELSEW.CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.24,
        "risk_count": 867,
        "predisposition_and_risk": 48,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1298536,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_427.3",
        "predisposition": "427.3* ATRIAL FIBRILLATION AND FLUTTER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.23,
        "risk_count": 811,
        "predisposition_and_risk": 48,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1132797,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_433.1",
        "predisposition": "433.1* OCCLUSION AND STENOSIS OF CAROTID ARTERY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.23,
        "risk_count": 867,
        "predisposition_and_risk": 90,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2450992,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_593.2",
        "predisposition": "593.2* CYST OF KIDNEY, ACQUIRED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.23,
        "risk_count": 811,
        "predisposition_and_risk": 41,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 961393,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_707.0",
        "predisposition": "707.0* DECUBITUS ULCER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.23,
        "risk_count": 811,
        "predisposition_and_risk": 88,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2069080,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_791.0",
        "predisposition": "791.0* PROTEINURIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.23,
        "risk_count": 867,
        "predisposition_and_risk": 115,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3138177,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_859.0",
        "predisposition": "859.0* HEAD TRAUMA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.23,
        "risk_count": 811,
        "predisposition_and_risk": 25,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 586630,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z96.7",
        "predisposition": "Z96.7* OTHER CONTINUOUS MECHANICAL VENTILATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.23,
        "risk_count": 811,
        "predisposition_and_risk": 37,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 870454,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_427.8",
        "predisposition": "427.8* OTHER SPECIFIED CARDIAC DYSRHYTHMIAS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 811,
        "predisposition_and_risk": 83,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1963664,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_735.0",
        "predisposition": "735.0* HALLUX VALGUS (ACQUIRED)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 685376,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_781.2",
        "predisposition": "781.2* ABNORMALITY OF GAIT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 811,
        "predisposition_and_risk": 22,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 522964,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z37.2",
        "predisposition": "Z37.2* DIAGNOSTIC PROCEDURES ON HEART AND PERICARDIUM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 811,
        "predisposition_and_risk": 113,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2677545,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_135_",
        "predisposition": "135 SARCOIDOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 867,
        "predisposition_and_risk": 54,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1479192,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_471_",
        "predisposition": "471 NASAL POLYPS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 811,
        "predisposition_and_risk": 25,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 593043,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_487_",
        "predisposition": "487 INFLUENZA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 811,
        "predisposition_and_risk": 26,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 616282,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_531_",
        "predisposition": "531 GASTRIC ULCER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 867,
        "predisposition_and_risk": 26,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 713080,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_805_",
        "predisposition": "805 # OF VERTEBRAL COLUMN WITHOUT SPINAL CORD INJURY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.22,
        "risk_count": 867,
        "predisposition_and_risk": 34,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 929752,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_859.0",
        "predisposition": "859.0* HEAD TRAUMA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.21,
        "risk_count": 867,
        "predisposition_and_risk": 27,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 743959,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z81.4",
        "predisposition": "Z81.4* ARTHROPLASTY OF KNEE AND ANKLE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.21,
        "risk_count": 811,
        "predisposition_and_risk": 28,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 667287,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z99.2",
        "predisposition": "Z99.2* INJECT.OR INFUSION OF OTHER THERAPEUTIC OR PROPHYLACTIC SUBS.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.21,
        "risk_count": 867,
        "predisposition_and_risk": 94,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2609413,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_435_",
        "predisposition": "435 TRANSIENT CEREBRAL ISCHEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.21,
        "risk_count": 867,
        "predisposition_and_risk": 58,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1603508,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_604_",
        "predisposition": "604 ORCHITIS AND EPIDIDYMITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.21,
        "risk_count": 811,
        "predisposition_and_risk": 33,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 786653,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_436",
        "predisposition": "436* ACUTE, BUT ILL-DEFINED, CEREBROVASCULAR DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.21,
        "risk_count": 867,
        "predisposition_and_risk": 34,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 940657,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_288.0",
        "predisposition": "288.0* AGRANULOCYTOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.2,
        "risk_count": 867,
        "predisposition_and_risk": 44,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1230649,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_355.0",
        "predisposition": "355.0* LESION OF SCIATIC NERVE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.2,
        "risk_count": 867,
        "predisposition_and_risk": 34,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 944952,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_366.1",
        "predisposition": "366.1* SENILE CATARACT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.2,
        "risk_count": 867,
        "predisposition_and_risk": 116,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3241400,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_569.4",
        "predisposition": "569.4* OTHER SPECIFIED DISORDERS OF RECTUM AND ANUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.2,
        "risk_count": 867,
        "predisposition_and_risk": 31,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 862182,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_793.1",
        "predisposition": "793.1* NONSPECIF.ABNORMAL FINDINGS LUNG FIELD,(COIN LESION)(SHADOW)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.2,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 553184,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_879.8",
        "predisposition": "879.8* OPEN WOUND(S)(MULTIPLE)OF UNSPECIFIED SITE(S),WITHOUT COMPLIC.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.2,
        "risk_count": 867,
        "predisposition_and_risk": 29,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 806804,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V45.8",
        "predisposition": "V45.8* OTHER POSTSURGICAL STATUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.2,
        "risk_count": 811,
        "predisposition_and_risk": 299,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 7196087,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z00.6",
        "predisposition": "Z00.6* PROCEDURES OF BLOOD VESSELS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.2,
        "risk_count": 811,
        "predisposition_and_risk": 74,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1783811,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_241.0",
        "predisposition": "241.0* NONTOXIC UNINODULAR GOITER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 561026,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.3",
        "predisposition": "362.3* RETINAL VASCULAR OCCLUSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 40,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 975501,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_373.2",
        "predisposition": "373.2* CHALAZION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 41,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1154521,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_413.9",
        "predisposition": "413.9* OTHER AND UNSPECIFIED ANGINA PECTORIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 117,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3293793,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_455.0",
        "predisposition": "455.0* INTERNAL HEMORRHOIDS WITHOUT MENTION OF COMPLICATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 49,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1379329,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_493.9",
        "predisposition": "493.9* ASTHMA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 64,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1560548,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_511.8",
        "predisposition": "511.8* OTHER SPECIFIED FORMS OF PLEURAL EFFUSION, EXCEPT TUBERCULOUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 35,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 983025,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_536.8",
        "predisposition": "536.8* DYSPEPSIA AND OTHER SPECIFIED DISORDERS OF FUNCTION OF STOMACH",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 78,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1897899,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_553.3",
        "predisposition": "553.3* DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 50,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1216370,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_690.1",
        "predisposition": "690.1* SEBORRHEIC DERMATITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 55,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1333936,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_722.1",
        "predisposition": "722.1* DISPL.OF THORACIC OR LUMBAR INTERVERT.DISC WITHOUT MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 83,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2011140,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_728.8",
        "predisposition": "728.8* OTHER DISORDERS OF MUSCLE, LIGAMENT, AND FASCIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 61,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1482068,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V15.0",
        "predisposition": "V15.0* PERSONAL HISTORY OF ALLERGY,OTHER THAN TO MEDICINAL AGENTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 29,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 814335,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V58.6",
        "predisposition": "V58.6* ENCOUNTER FOR LONG-TERM (CURRENT) DRUG USE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 331,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 8046035,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z39.6",
        "predisposition": "Z39.6* PROCEDURES AUXILIARY TO OPEN HEART SURGERY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 24,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 580827,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z39.9",
        "predisposition": "Z39.9* OTHER OPERATIONS ON VESSELS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 103,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2899776,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_368_",
        "predisposition": "368 VISUAL DISTURBANCES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 811,
        "predisposition_and_risk": 38,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 922038,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_386_",
        "predisposition": "386 VERTIGINOUS SYNDROMES AND OTHER DISORDERS OF VESTIBULAR SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 32,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 900297,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_D90",
        "predisposition": "D90* HIATUS (DIAPHR.) HERNIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 615859,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L13",
        "predisposition": "L13* HIP SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 142,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4000498,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P74",
        "predisposition": "P74* ANXIETY DISORDER/ANXIETY STATE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.19,
        "risk_count": 867,
        "predisposition_and_risk": 40,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1127212,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_241.1",
        "predisposition": "241.1* NONTOXIC MULTINODULAR GOITER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 114,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3225934,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_401.1",
        "predisposition": "401.1* BENIGN ESSENTIAL HYPERTENSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 706749,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_427.6",
        "predisposition": "427.6* PREMATURE BEATS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 710489,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_528.0",
        "predisposition": "528.0* STOMATITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 707102,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_555.9",
        "predisposition": "555.9* REGIONAL ENTERITIS OF UNSPECIFIED SITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 35,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 993631,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_584.9",
        "predisposition": "584.9* ACUTE RENAL FAILURE, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 53,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1507871,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_715.0",
        "predisposition": "715.0* OSTEOARTHROSIS, GENERALIZED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 52,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1475023,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_726.6",
        "predisposition": "726.6* ENTHESOPATHY OF KNEE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 39,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1101477,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_733.0",
        "predisposition": "733.0* OSTEOPOROSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 811,
        "predisposition_and_risk": 76,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1863960,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V10.3",
        "predisposition": "V10.3* PERSONAL HISTORY OF MALIGNANT NEOPLASM OF BREAST",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 37,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1053207,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z36.0",
        "predisposition": "Z36.0* REMOVAL OF CORONARY ARTERY OBSTRUCTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 66,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1869324,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_278_",
        "predisposition": "278 OBESITY AND OTHER HYPERALIMENTATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 811,
        "predisposition_and_risk": 33,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 806169,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_D89",
        "predisposition": "D89* INGUINAL HERNIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 811,
        "predisposition_and_risk": 85,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2082714,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L92",
        "predisposition": "L92* SHOULDER SYNDROME",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.18,
        "risk_count": 867,
        "predisposition_and_risk": 37,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1047789,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_009.2",
        "predisposition": "009.2* INFECTIOUS DIARRHEA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 811,
        "predisposition_and_risk": 50,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1233330,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_245.2",
        "predisposition": "245.2* CHRONIC LYMPHOCYTIC THYROIDITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 34,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 968217,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_366.9",
        "predisposition": "366.9* UNSPECIFIED CATARACT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 33,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 942244,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_438.9",
        "predisposition": "438.9* UNSP. LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 811,
        "predisposition_and_risk": 40,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 986851,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_438.9",
        "predisposition": "438.9* UNSP. LATE EFFECTS OF CEREBROVASCULAR DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 23,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 657313,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_714.0",
        "predisposition": "714.0* RHEUMATOID ARTHRITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 120,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3432962,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_726.7",
        "predisposition": "726.7* ENTHESOPATHY OF ANKLE AND TARSUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 811,
        "predisposition_and_risk": 100,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2474897,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_729.8",
        "predisposition": "729.8* OTHER MUSCULOSKELETAL SYMPTOMS REFERABLE TO LIMBS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 96,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2733311,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_789.5",
        "predisposition": "789.5* ASCITES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 48,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1375906,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_995.9",
        "predisposition": "995.9* SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 811,
        "predisposition_and_risk": 34,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 838161,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V15.8",
        "predisposition": "V15.8* OTHER SPECIFIED PERSONAL HISTORY PRESENTING HAZARDS TO HEALTH",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 55,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1572045,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V58.6",
        "predisposition": "V58.6* ENCOUNTER FOR LONG-TERM (CURRENT) DRUG USE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 253,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 7252816,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z99.1",
        "predisposition": "Z99.1* INJECT.OR INFUSION OF THERAPEUTIC OR PROPHYLACTIC SUBSTANCE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 739237,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_357_",
        "predisposition": "357 INFLAMMATORY AND TOXIC NEUROPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 867,
        "predisposition_and_risk": 50,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1427296,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_436",
        "predisposition": "436* ACUTE, BUT ILL-DEFINED, CEREBROVASCULAR DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 811,
        "predisposition_and_risk": 59,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1455953,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L11",
        "predisposition": "L11* WRIST SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.17,
        "risk_count": 811,
        "predisposition_and_risk": 24,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 593703,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_110.5",
        "predisposition": "110.5* DERMATOPHYTOSIS OF THE BODY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 50,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1245601,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_250.0",
        "predisposition": "250.0* DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 166,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4152736,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_373.1",
        "predisposition": "373.1* HORDEOLUM AND OTHER DEEP INFLAMMATION OF EYELID",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 744799,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_377.1",
        "predisposition": "377.1* OPTIC ATROPHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 25,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 624035,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_511.9",
        "predisposition": "511.9* UNSPECIFIED PLEURAL EFFUSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 867,
        "predisposition_and_risk": 30,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 865272,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_578.9",
        "predisposition": "578.9* HEMORRHAGE OF GASTROINTESTINAL TRACT, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 37,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 921122,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_707.0",
        "predisposition": "707.0* DECUBITUS ULCER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 867,
        "predisposition_and_risk": 55,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1589763,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_783.2",
        "predisposition": "783.2* ABNORMAL LOSS OF WEIGHT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 867,
        "predisposition_and_risk": 121,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3498280,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_794.3",
        "predisposition": "794.3* NONSPECIFIC ABNORMAL RESULTS OF CARDIOVASCULAR SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 25,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 624972,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_999.9",
        "predisposition": "999.9* UNSPECIFIED COMPLICATIONS OF MEDICAL CARE,NOT ELSEW.CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 58,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1445477,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_E88.8",
        "predisposition": "E88.8* OTHER AND UNSPECIFIED ACCIDENTAL FALL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 867,
        "predisposition_and_risk": 154,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4439284,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V17.3",
        "predisposition": "V17.3* FAMILY HISTORY OF ISCHEMIC HEART DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 71,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1766475,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z36.0",
        "predisposition": "Z36.0* REMOVAL OF CORONARY ARTERY OBSTRUCTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 185,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4628794,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z85.2",
        "predisposition": "Z85.2* EXCISION OR DESTRUCTION OF BREAST TISSUE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 867,
        "predisposition_and_risk": 30,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 864705,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_219_",
        "predisposition": "219 OTHER BENIGN NEOPLASM OF UTERUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 867,
        "predisposition_and_risk": 27,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 777639,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_389_",
        "predisposition": "389 HEARING LOSS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.16,
        "risk_count": 811,
        "predisposition_and_risk": 184,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4603747,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_173.9",
        "predisposition": "173.9* OTHER MALIGNANT NEOPLASM OF SKIN, SITE UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 133,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3879794,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_250.0",
        "predisposition": "250.0* DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 143,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4161106,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_272.2",
        "predisposition": "272.2* MIXED HYPERLIPIDEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 811,
        "predisposition_and_risk": 35,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 876462,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_308.0",
        "predisposition": "308.0* PREDOMINANT DISTURBANCE OF EMOTIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 41,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1193591,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_375.2",
        "predisposition": "375.2* EPIPHORA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 30,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 870253,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_389.1",
        "predisposition": "389.1* SENSORINEURAL HEARING LOSS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 811,
        "predisposition_and_risk": 156,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3920176,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_627.2",
        "predisposition": "627.2* MENOPAUSAL OR FEMALE CLIMACTERIC STATES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 56,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1630430,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_702.1",
        "predisposition": "702.1* SEBORRHEIC HERATOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 811,
        "predisposition_and_risk": 35,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 882420,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_709.0",
        "predisposition": "709.0* DYSCHROMIA, ANOMALOUS PIGMENTATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 811,
        "predisposition_and_risk": 56,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1406524,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_724.0",
        "predisposition": "724.0* SPINAL STENOSIS, OTHER THAN CERVICAL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 107,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3105382,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_733.0",
        "predisposition": "733.0* OSTEOPOROSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 425,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 12358772,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_782.0",
        "predisposition": "782.0* DISTURBANCE OF SKIN SENSATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 167,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4840632,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_923.0",
        "predisposition": "923.0* CONTUSION OF SHOULDER AND UPPER ARM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 811,
        "predisposition_and_risk": 38,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 956898,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_923.2",
        "predisposition": "923.2* CONTUSION OF WRIST AND HAND(S), EXCEPT FINGER(S) ALONE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 61,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1775673,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V43.1",
        "predisposition": "V43.1* LENS REPLACED BY OTHER MEANS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 811,
        "predisposition_and_risk": 43,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1082429,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z88.7",
        "predisposition": "Z88.7* DIAGNOSTIC ULTRASOUND",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 811,
        "predisposition_and_risk": 120,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3017985,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_244_",
        "predisposition": "244 ACQUIRED HYPOTHYROIDISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 59,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1715616,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_531_",
        "predisposition": "531 GASTRIC ULCER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 811,
        "predisposition_and_risk": 27,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 679755,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_B82",
        "predisposition": "B82* ANEMIA OTHER/UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.15,
        "risk_count": 867,
        "predisposition_and_risk": 161,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4675848,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_053.9",
        "predisposition": "053.9* HERPES ZOSTER WITHOUT MENTION OF COMPLICATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 867,
        "predisposition_and_risk": 79,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2313926,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_172.9",
        "predisposition": "172.9* MELANOMA OF SKIN, SITE UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 811,
        "predisposition_and_risk": 38,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 960435,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_287.2",
        "predisposition": "287.2* OTHER NONTHROMBOCYTOPENIC PURPURAS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 811,
        "predisposition_and_risk": 46,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1163144,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_367.1",
        "predisposition": "367.1* MYOPIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 867,
        "predisposition_and_risk": 143,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4194416,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_379.3",
        "predisposition": "379.3* APHAKIA AND OTHER DISORDERS OF LENS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 811,
        "predisposition_and_risk": 75,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1904734,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_381.0",
        "predisposition": "381.0* ACUTE NONSUPPURATIVE OTITIS MEDIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 811,
        "predisposition_and_risk": 60,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1523700,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_623.5",
        "predisposition": "623.5* LEUKORRHEA, NOT SPECIFIED AS INFECTIVE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 867,
        "predisposition_and_risk": 37,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1083937,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_710.0",
        "predisposition": "710.0* SYSTEMIC LUPUS ERYTHEMATOSUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 867,
        "predisposition_and_risk": 32,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 938065,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_788.3",
        "predisposition": "788.3* INCONTINENCE OF URINE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 811,
        "predisposition_and_risk": 103,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2612547,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z13.7",
        "predisposition": "Z13.7* INSERTION OF PROSTHETIC LENS (PSEUDOPHAKOS)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 867,
        "predisposition_and_risk": 104,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3045814,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z99.1",
        "predisposition": "Z99.1* INJECT.OR INFUSION OF THERAPEUTIC OR PROPHYLACTIC SUBSTANCE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 702879,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_8",
        "predisposition": "8* DIABETES ROUTINE FOLLOW UP",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.14,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 643626,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_078.1",
        "predisposition": "078.1* VIRAL WARTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 93,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2744658,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_211.3",
        "predisposition": "211.3* BENIGN NEOPLASM OF COLON",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 77,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2281963,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_228.0",
        "predisposition": "228.0* HEMANGIOMA, ANY SITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 52,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1545617,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_276.8",
        "predisposition": "276.8* HYPOPOTASSEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 26,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 662631,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.3",
        "predisposition": "362.3* RETINAL VASCULAR OCCLUSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 35,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1032313,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.5",
        "predisposition": "362.5* DEGENERATION OF MACULA AND POSTERIOR POLE OF RETINA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 70,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1794718,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_365.0",
        "predisposition": "365.0* BORDERLINE GLAUCOMA (GLAUCOMA SUSPECT)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 56,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1432925,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_472.0",
        "predisposition": "472.0* CHRONIC RHINITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 36,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1067582,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_618.0",
        "predisposition": "618.0* PROLAPSE OF VAGINAL WALLS WITHOUT MENTION OF UTERINE PROLAPSE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 83,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2464566,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_702.9",
        "predisposition": "702.9* ACTINIC KERATOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 28,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 714866,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_706.8",
        "predisposition": "706.8* OTHER SPECIFIED DISEASES OF SEBACEOUS GLANDS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 51,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1301180,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_714.0",
        "predisposition": "714.0* RHEUMATOID ARTHRITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 41,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1046379,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.4",
        "predisposition": "785.4* GANGRENE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 45,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1151691,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790.6",
        "predisposition": "790.6* OTHER ABNORMAL BLOOD CHEMISTRY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 77,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2287948,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V14.6",
        "predisposition": "V14.6* PERSONAL HISTORY OF ALLERGY TO ANALGESIC AGENT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 26,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 663581,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V15.8",
        "predisposition": "V15.8* OTHER SPECIFIED PERSONAL HISTORY PRESENTING HAZARDS TO HEALTH",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 146,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3740867,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_272_",
        "predisposition": "272 DISORDERS OF LIPOID METABOLISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 76,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1947595,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_702_",
        "predisposition": "702 OTHER DERMATOSES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 163,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4836956,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_460",
        "predisposition": "460* ACUTE NASOPHARYNGITIS (COMMON COLD)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 121,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3577911,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_486",
        "predisposition": "486* PNEUMONIA, ORGANISM UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 867,
        "predisposition_and_risk": 220,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 6525999,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_B82",
        "predisposition": "B82* ANEMIA OTHER/UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 171,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4394607,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L16",
        "predisposition": "L16* ANKLE SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.13,
        "risk_count": 811,
        "predisposition_and_risk": 62,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1585876,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_276.5",
        "predisposition": "276.5* VOLUME DEPLETION DISORDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 27,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 700140,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_285.2",
        "predisposition": "285.2* ANEMIA IN CHRONIC ILLNESS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 51,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1319134,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_342.9",
        "predisposition": "342.9* HEMIPLEGIA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 36,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 928910,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_355.0",
        "predisposition": "355.0* LESION OF SCIATIC NERVE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 29,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 749200,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_355.1",
        "predisposition": "355.1* MERALGIA PARESTHETICA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 60,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1796650,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_364.3",
        "predisposition": "364.3* UNSPECIFIED IRIDOCYCLITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 23,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 685912,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_365.0",
        "predisposition": "365.0* BORDERLINE GLAUCOMA (GLAUCOMA SUSPECT)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 76,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2266174,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_373.2",
        "predisposition": "373.2* CHALAZION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 36,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 927425,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_459.8",
        "predisposition": "459.8* OTHER SPECIFIED DISORDERS OF CIRCULATORY SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 48,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1238690,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_562.1",
        "predisposition": "562.1* DIVERTICULA OF COLON",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 56,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1445925,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_569.4",
        "predisposition": "569.4* OTHER SPECIFIED DISORDERS OF RECTUM AND ANUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 34,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 876932,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_599.0",
        "predisposition": "599.0* URINARY TRACT INFECTION, SITE NOT SPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 275,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 7087346,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_923.0",
        "predisposition": "923.0* CONTUSION OF SHOULDER AND UPPER ARM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 51,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1526567,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_P02.7",
        "predisposition": "P02.7* ISSUE OF MEDICAL CERTIFICATE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 54,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1400053,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V14.6",
        "predisposition": "V14.6* PERSONAL HISTORY OF ALLERGY TO ANALGESIC AGENT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 38,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1131183,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z00.6",
        "predisposition": "Z00.6* PROCEDURES OF BLOOD VESSELS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 713657,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z13.4",
        "predisposition": "Z13.4* EXTRACAPS.EXTRACT.OF LENS BY FRAGMENT.AND ASPIRATION TECHN.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 87,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2609689,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z87.0",
        "predisposition": "Z87.0* SOFT TISSUE X-RAY OF FACE, HEAD, AND NECK",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 47,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1403384,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_268_",
        "predisposition": "268 VITAMIN D DEFICIENCY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 85,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2201647,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_523_",
        "predisposition": "523 GINGIVAL AND PERIODONTAL DISEASES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 715517,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_035",
        "predisposition": "035* ERYSIPELAS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 37,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 957519,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_460",
        "predisposition": "460* ACUTE NASOPHARYNGITIS (COMMON COLD)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 87,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2253174,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L03",
        "predisposition": "L03* LOW BACK COMPLT.W/O RADIATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 112,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2892030,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L17",
        "predisposition": "L17* FOOT & TOE SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.12,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 823585,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_078.1",
        "predisposition": "078.1* VIRAL WARTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 78,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2035979,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_351.0",
        "predisposition": "351.0* BELL'S PALSY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 867,
        "predisposition_and_risk": 39,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1170676,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_401.9",
        "predisposition": "401.9* UNSPECIFIED ESSENTIAL HYPERTENSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 867,
        "predisposition_and_risk": 369,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 11102299,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_427.6",
        "predisposition": "427.6* PREMATURE BEATS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 780824,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_433.1",
        "predisposition": "433.1* OCCLUSION AND STENOSIS OF CAROTID ARTERY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 136,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3558586,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_443.8",
        "predisposition": "443.8* OTHER SPECIFIED PERIPHERAL VASCULAR DISEASES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 41,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1063426,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_571.8",
        "predisposition": "571.8* OTHER CHRONIC NONALCOHOLIC LIVER DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 867,
        "predisposition_and_risk": 128,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3870637,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_607.8",
        "predisposition": "607.8* OTHER SPECIFIED DISORDERS OF PENIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 178,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4619579,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_618.1",
        "predisposition": "618.1* UTERINE PROLAPSE WITHOUT MENTION OF VAGINAL WALL PROLAPSE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 753212,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_695.8",
        "predisposition": "695.8* OTHER SPECIFIED ERYTHEMATOUS CONDITIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 33,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 860841,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_727.0",
        "predisposition": "727.0* SYNOVITIS AND TENOSYNOVITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 151,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3921036,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_729.1",
        "predisposition": "729.1* MYALGIA AND MYOSITIS, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 84,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2180272,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_787.9",
        "predisposition": "787.9* OTHER SYMPTOMS INVOLVING DIGESTIVE SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 142,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3695690,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_788.3",
        "predisposition": "788.3* INCONTINENCE OF URINE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 867,
        "predisposition_and_risk": 191,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5772714,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_799.9",
        "predisposition": "799.9* UNKNOWN OR UNSPECIFIED CAUSE OF MORBIDITY (DIAGNOSIS DEFERRED)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 548954,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V14.0",
        "predisposition": "V14.0* PERSONAL HISTORY OF ALLERGY TO PENICILLIN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 867,
        "predisposition_and_risk": 66,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1991675,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V16.0",
        "predisposition": "V16.0* FAMILY HISTORY OF MALIGNANT NEOPLASM OF GASTROINTESTINAL TRACT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 784085,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V45.1",
        "predisposition": "V45.1* (POSTSURGICAL)RENAL DIALYSIS STATUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 91,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2367121,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.7",
        "predisposition": "Z88.7* DIAGNOSTIC ULTRASOUND",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 867,
        "predisposition_and_risk": 132,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3987299,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L03",
        "predisposition": "L03* LOW BACK COMPLT.W/O RADIATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 867,
        "predisposition_and_risk": 140,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4235114,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L90",
        "predisposition": "L90* OSTEOARTHRITIS OF KNEE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.11,
        "risk_count": 811,
        "predisposition_and_risk": 137,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3567505,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_211.3",
        "predisposition": "211.3* BENIGN NEOPLASM OF COLON",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 99,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2592030,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_251.2",
        "predisposition": "251.2* HYPOGLYCEMIA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 867,
        "predisposition_and_risk": 50,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1517041,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_375.1",
        "predisposition": "375.1* OTHER DISORDERS OF LACRIMAL GLAND",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 150,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3926809,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_715.9",
        "predisposition": "715.9* OSTEOARTHROSIS, UNSPECIFIED WHETHER GENERALIZED OR LOCALIZED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 867,
        "predisposition_and_risk": 21,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 637427,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.3",
        "predisposition": "780.3* CONVULSIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 844824,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.9",
        "predisposition": "780.9* OTHER GENERAL SYMPTOMS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 867,
        "predisposition_and_risk": 105,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3196317,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_788.1",
        "predisposition": "788.1* DYSURIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 155,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4079421,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_799.8",
        "predisposition": "799.8* OTHER ILL-DEFINED CONDITIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 120,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3144870,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_836.0",
        "predisposition": "836.0* TEAR OF MEDIAL CARTILAGE OR MENISCUS OF KNEE, CURRENT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 731722,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_879.8",
        "predisposition": "879.8* OPEN WOUND(S)(MULTIPLE)OF UNSPECIFIED SITE(S),WITHOUT COMPLIC.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 42,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1100599,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V16.3",
        "predisposition": "V16.3* FAMILY HISTORY OF MALIGNANT NEOPLASM OF BREAST",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 867,
        "predisposition_and_risk": 84,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2565766,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z89.3",
        "predisposition": "Z89.3* OTHER ANATOMIC-PHYSIOLOGIC MEASUREMENTS AND MANUAL EXAMINAT.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 867,
        "predisposition_and_risk": 75,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2288526,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_366_",
        "predisposition": "366 CATARACT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 429,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 11246696,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_412_",
        "predisposition": "412 OLD MYOCARDIAL INFARCTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 146,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3836761,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_461_",
        "predisposition": "461 ACUTE SINUSITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 116,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3039980,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_S18",
        "predisposition": "S18* LACERATION/CUT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.1,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 788171,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_280.9",
        "predisposition": "280.9* IRON DEFICIENCY ANEMIA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 281,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 7481007,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_280.9",
        "predisposition": "280.9* IRON DEFICIENCY ANEMIA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 307,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 9441757,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_296.2",
        "predisposition": "296.2* MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 68,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1802640,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_354.0",
        "predisposition": "354.0* CARPAL TUNNEL SYNDROME",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 128,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3380713,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_374.8",
        "predisposition": "374.8* OTHER DISORDERS OF EYELID",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 30,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 921670,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_379.2",
        "predisposition": "379.2* DISORDERS OF VITREOUS BODY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 117,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3098588,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_388.7",
        "predisposition": "388.7* OTALGIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 83,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2551557,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_428.1",
        "predisposition": "428.1* LEFT HEART FAILURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 26,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 799074,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_455.0",
        "predisposition": "455.0* INTERNAL HEMORRHOIDS WITHOUT MENTION OF COMPLICATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 56,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1490407,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_478.1",
        "predisposition": "478.1* OTHER DISEASES OF NASAL CAVITY AND SINUSES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 40,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1225501,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_564.0",
        "predisposition": "564.0* CONSTIPATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 216,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5710894,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_682.6",
        "predisposition": "682.6* CELLULITIS AND ABSCESS OF LEG, EXCEPT FOOT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 24,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 637534,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_695.8",
        "predisposition": "695.8* OTHER SPECIFIED ERYTHEMATOUS CONDITIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 56,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1717177,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_702.0",
        "predisposition": "702.0* ACTINIC KERATOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 115,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3518566,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_716.9",
        "predisposition": "716.9* UNSPECIFIED ARTHROPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 46,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1223583,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P76.0",
        "predisposition": "P76.0* ISSUE OF REPEAT PRESCRIPTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 36,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1100853,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V44.0",
        "predisposition": "V44.0* TRACHEOSTOMY STATUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 31,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 824444,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V57.8",
        "predisposition": "V57.8* CARE INVOLVING OTHER SPECIFIED REHABILITATION PROCEDURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 24,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 637268,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z13.7",
        "predisposition": "Z13.7* INSERTION OF PROSTHETIC LENS (PSEUDOPHAKOS)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 97,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2577939,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z88.5",
        "predisposition": "Z88.5* ANGIOCARDIOGRAPHY USING CONTRAST MATERIAL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 202,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5361875,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_272_",
        "predisposition": "272 DISORDERS OF LIPOID METABOLISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 78,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2393222,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_365_",
        "predisposition": "365 GLAUCOMA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 193,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5136565,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_477_",
        "predisposition": "477 ALLERGIC RHINITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 85,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2262971,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_698_",
        "predisposition": "698 PRURITUS AND RELATED CONDITIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 36,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1102204,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_485",
        "predisposition": "485* BRONCHOPNEUMONIA, ORGANISM UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 676097,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_T82",
        "predisposition": "T82* OBESITY (BMI >30)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.09,
        "risk_count": 811,
        "predisposition_and_risk": 131,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3484033,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_216.9",
        "predisposition": "216.9* BENIGN NEOPLASM OF SKIN, SITE UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 127,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3387860,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_266.2",
        "predisposition": "266.2* OTHER B-COMPLEX DEFICIENCIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 144,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3872891,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_278.0",
        "predisposition": "278.0* OBESITY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 300,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 7998615,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_285.9",
        "predisposition": "285.9* ANEMIA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 134,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3594055,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_307.8",
        "predisposition": "307.8* PSYCHALGIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 57,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1757465,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.0",
        "predisposition": "362.0* DIABETIC RETINOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 47,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1255446,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_366.1",
        "predisposition": "366.1* SENILE CATARACT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 92,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2453039,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_401.9",
        "predisposition": "401.9* UNSPECIFIED ESSENTIAL HYPERTENSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 422,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 11332935,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_464.1",
        "predisposition": "464.1* ACUTE TRACHEITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 30,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 930932,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_535.0",
        "predisposition": "535.0* __GASTRITIS____1992 ACUTE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 97,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3014924,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_600.0",
        "predisposition": "600.0* HYPERTROPHY (BENIGN) OF PROSTATE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 417,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 11129350,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_722.0",
        "predisposition": "722.0* DISPLACEM.OF CERVICAL INTERVERTEBR.DISC WITHOUT MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 33,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1018080,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_728.8",
        "predisposition": "728.8* OTHER DISORDERS OF MUSCLE, LIGAMENT, AND FASCIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 62,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1923113,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_782.2",
        "predisposition": "782.2* LOCALIZED SUPERFICIAL SWELLING, MASS, OR LUMP",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 32,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 994888,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_787.3",
        "predisposition": "787.3* FLATULENCE, ERUCTATION, AND GAS PAIN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 29,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 773557,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_836.0",
        "predisposition": "836.0* TEAR OF MEDIAL CARTILAGE OR MENISCUS OF KNEE, CURRENT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 560972,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_922.1",
        "predisposition": "922.1* CONTUSION OF CHEST WALL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 58,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1546209,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_924.2",
        "predisposition": "924.2* CONTUSION OF ANKLE AND FOOT, EXCLUDING TOE(S)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 34,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1051643,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z39.9",
        "predisposition": "Z39.9* OTHER OPERATIONS ON VESSELS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 145,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3896892,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z51.2",
        "predisposition": "Z51.2* CHOLECYSTECTOMY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 36,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 967578,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z89.0",
        "predisposition": "Z89.0* DIAGNOSTIC INTERVIEW, CONSULTATION, AND EVALUATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 101,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3120794,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_411_",
        "predisposition": "411 OTHER ACUTE AND SUBACUTE FORMS OF ISCHEMIC HEART DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 405,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 10807146,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_443_",
        "predisposition": "443 OTHER PERIPHERAL VASCULAR DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 53,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1648310,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_525_",
        "predisposition": "525 DISEASES AND CONDITIONS OF THE TEETH AND SUPPORT.STRUCTURES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 216,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5757822,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_702_",
        "predisposition": "702 OTHER DERMATOSES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 112,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2986577,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_F92_",
        "predisposition": "F92 MIXED DISORDERS OF CONDUCT EMOTIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 83,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2575974,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V67_",
        "predisposition": "V67 FOLLOW-UP EXAMINATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 339,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 9078572,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_486",
        "predisposition": "486* PNEUMONIA, ORGANISM UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 811,
        "predisposition_and_risk": 232,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 6224895,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L14",
        "predisposition": "L14* LEG/THIGH SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.08,
        "risk_count": 867,
        "predisposition_and_risk": 105,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3237939,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_009.2",
        "predisposition": "009.2* INFECTIOUS DIARRHEA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 56,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1757699,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_110.4",
        "predisposition": "110.4* DERMATOPHYTOSIS OF FOOT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 126,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3955958,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_276.7",
        "predisposition": "276.7* HYPERPOTASSEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 73,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2283965,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_411.1",
        "predisposition": "411.1* INTERMEDIATE CORONARY SYNDROME",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 95,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2570562,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_428.0",
        "predisposition": "428.0* CONGESTIVE HEART FAILURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 812213,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_459.8",
        "predisposition": "459.8* OTHER SPECIFIED DISORDERS OF CIRCULATORY SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 69,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2160299,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_493.9",
        "predisposition": "493.9* ASTHMA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 113,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3524242,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_702.0",
        "predisposition": "702.0* ACTINIC KERATOSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 132,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3553032,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_706.3",
        "predisposition": "706.3* SEBORRHEA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 619015,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_724.5",
        "predisposition": "724.5* BACKACHE, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 265,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 7140099,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_726.0",
        "predisposition": "726.0* ADHESIVE CAPSULITIS OF SHOULDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 25,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 783654,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_726.1",
        "predisposition": "726.1* ROTATOR CUFF SYNDROME OF SHOULDER AND ALLIED DISORDERS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 271,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 8438779,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_726.7",
        "predisposition": "726.7* ENTHESOPATHY OF ANKLE AND TARSUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 156,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4886186,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_729.5",
        "predisposition": "729.5* PAIN IN LIMB",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 566,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 17670221,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.5",
        "predisposition": "780.5* SLEEP DISTURBANCES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 321,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 8689401,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_782.1",
        "predisposition": "782.1* RASH AND OTHER NONSPECIFIC SKIN ERUPTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 43,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1162495,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_783.2",
        "predisposition": "783.2* ABNORMAL LOSS OF WEIGHT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 119,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3211610,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_786.0",
        "predisposition": "786.0* DYSPNEA AND RESPIRATORY ABNORMALITIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 419,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 13113036,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_786.3",
        "predisposition": "786.3* HEMOPTYSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 44,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1191892,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_787.9",
        "predisposition": "787.9* OTHER SYMPTOMS INVOLVING DIGESTIVE SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 167,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5196892,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_816.0",
        "predisposition": "816.0* CLOSED FRACTURE OF ONE OR MORE PHALANGES OF HAND",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 688381,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_996.7",
        "predisposition": "996.7* COMPLICATION OF INTERNAL PROSTHETIC DEVICE,IMPLANT,GRAFT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 26,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 702413,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V45.1",
        "predisposition": "V45.1* (POSTSURGICAL)RENAL DIALYSIS STATUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 56,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1757248,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V72.6",
        "predisposition": "V72.6* LABORATORY EXAMINATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 414,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 12946312,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z81.5",
        "predisposition": "Z81.5* TOTAL HIP REPLACEMENT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 38,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1187476,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z85.4",
        "predisposition": "Z85.4* MASTECTOMY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 33,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1028917,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_357_",
        "predisposition": "357 INFLAMMATORY AND TOXIC NEUROPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 63,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1709199,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_366_",
        "predisposition": "366 CATARACT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 494,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 15406728,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_680_",
        "predisposition": "680 CARBUNCLE AND FURUNCLE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 32,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 998147,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_A03",
        "predisposition": "A03* FEVER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 154,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4175026,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_A97",
        "predisposition": "A97* NO DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 125,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3391072,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L10",
        "predisposition": "L10* ELBOW SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 812642,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_U80",
        "predisposition": "U80* INJURIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.07,
        "risk_count": 867,
        "predisposition_and_risk": 83,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2595366,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_257.2",
        "predisposition": "257.2* OTHER TESTICULAR HYPOFUNCTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 22,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 600986,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_272.0",
        "predisposition": "272.0* PURE HYPERCHOLESTEROLEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 436,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 11934786,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_273.8",
        "predisposition": "273.8* OTHER DISORDERS OF PLASMA PROTEIN METABOLISM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 630242,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_305.1",
        "predisposition": "305.1* TOBACCO USE DISORDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 448,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 12195380,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_332.0",
        "predisposition": "332.0* PARALYSIS AGITANS, PARKINSON'S DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 78,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2121427,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_368.8",
        "predisposition": "368.8* OTHER SPECIFIED VISUAL DISTURBANCES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 46,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1249342,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_372.4",
        "predisposition": "372.4* PTERYGIUM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 64,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1745869,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_379.2",
        "predisposition": "379.2* DISORDERS OF VITREOUS BODY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 170,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5340742,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_414.0",
        "predisposition": "414.0* CORONARY ATHEROSCLEROSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 216,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5872005,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_451.1",
        "predisposition": "451.1* PHLEBITIS AND THROMBOPHLEBITIS,DEEP VESSELS LOWER EXTREMITIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 61,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1660060,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_454.0",
        "predisposition": "454.0* VARICOSE VEINS OF LOWER EXTREMITIES WITH ULCER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 33,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1041660,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_511.8",
        "predisposition": "511.8* OTHER SPECIFIED FORMS OF PLEURAL EFFUSION, EXCEPT TUBERCULOUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 50,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1359450,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_530.1",
        "predisposition": "530.1* ESOPHAGITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 257,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 8095536,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_553.2",
        "predisposition": "553.2* VENTRAL HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 56,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1762652,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_565.0",
        "predisposition": "565.0* ANAL FISSURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 44,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1384235,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_574.2",
        "predisposition": "574.2* CALCULUS OF GALLBLADDER WITHOUT MENTION OF CHOLECYSTITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 126,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3984718,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_592.1",
        "predisposition": "592.1* CALCULUS OF URETER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 32,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 876788,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_599.7",
        "predisposition": "599.7* HEMATURIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 179,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4883015,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_600.9",
        "predisposition": "600.9* UNSPECIFIED HYPERPLASIA OF PROSTATE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 167,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4568351,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_611.7",
        "predisposition": "611.7* SIGNS AND SYMPTOMS IN BREAST",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 145,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4569615,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_682.9",
        "predisposition": "682.9* CELLULITIS AND ABSCESS OF UNSPECIFIED SITES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 183,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4997373,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_682.9",
        "predisposition": "682.9* CELLULITIS AND ABSCESS OF UNSPECIFIED SITES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 171,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5409226,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_721.0",
        "predisposition": "721.0* CERVICAL SPONDYLOSIS WITHOUT MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 57,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1805941,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_721.3",
        "predisposition": "721.3* LUMBOSACRAL SPONDYLOSIS WITHOUT MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 34,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 927690,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_784.5",
        "predisposition": "784.5* OTHER SPEECH DISTURBANCE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 53,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1439625,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_786.0",
        "predisposition": "786.0* DYSPNEA AND RESPIRATORY ABNORMALITIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 429,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 11695668,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_786.5",
        "predisposition": "786.5* CHEST PAIN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 383,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 12067243,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_799.3",
        "predisposition": "799.3* DEBILITY, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 144,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4539188,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V46.2",
        "predisposition": "V46.2* DEPENDENCE ON SUPPLEMENTAL OXYGEN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 26,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 707454,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z84.1",
        "predisposition": "Z84.1* AMPUTATION OF LOWER LIMB",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 811,
        "predisposition_and_risk": 83,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2260848,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z89.5",
        "predisposition": "Z89.5* OTHER NONOPERATIVE CARDIAC AND VASCULAR DIAGNOSTIC PROCEDURES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.06,
        "risk_count": 867,
        "predisposition_and_risk": 54,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1708611,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_112.1",
        "predisposition": "112.1* CANDIDIASIS OF VULVA AND VAGINA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 40,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1278551,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_278.0",
        "predisposition": "278.0* OBESITY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 325,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 10350287,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_354.0",
        "predisposition": "354.0* CARPAL TUNNEL SYNDROME",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 223,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 7087591,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_380.4",
        "predisposition": "380.4* IMPACTED CERUMEN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 205,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 6504935,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_413.9",
        "predisposition": "413.9* OTHER AND UNSPECIFIED ANGINA PECTORIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 180,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4947773,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_447.1",
        "predisposition": "447.1* STRICTURE OF ARTERY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 31,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 852581,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_553.1",
        "predisposition": "553.1* UMBILICAL HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 38,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1206681,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_562.1",
        "predisposition": "562.1* DIVERTICULA OF COLON",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 64,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2032942,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_571.8",
        "predisposition": "571.8* OTHER CHRONIC NONALCOHOLIC LIVER DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 83,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2292332,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_616.1",
        "predisposition": "616.1* VAGINITIS AND VULVOVAGINITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 74,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2350084,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_698.3",
        "predisposition": "698.3* LICHENIFICATION AND LICHEN SIMPLEX CHRONICUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 632242,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_723.1",
        "predisposition": "723.1* CERVICALGIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 333,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 9203081,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_729.5",
        "predisposition": "729.5* PAIN IN LIMB",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 446,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 12265502,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_784.7",
        "predisposition": "784.7* EPISTAXIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 58,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1839894,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_785.6",
        "predisposition": "785.6* ENLARGEMENT OF LYMPH NODES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 75,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2378358,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_787.0",
        "predisposition": "787.0* NAUSEA AND VOMITING",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 122,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3884310,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_787.2",
        "predisposition": "787.2* DYSPHAGIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 66,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2108485,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_788.2",
        "predisposition": "788.2* RETENTION OF URINE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 91,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2499525,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_788.4",
        "predisposition": "788.4* FREQUENCY OF URINATION AND POLYURIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 149,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4121828,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V14.8",
        "predisposition": "V14.8* PERSONAL HISTORY OF ALLERGY TO SPECIFIED MEDICINAL AGENTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 84,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2688556,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V70.0",
        "predisposition": "V70.0* ROUTINE GENERAL MEDICAL EXAMINATION AT A HEALTH CARE FACILITY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 66,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2096683,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z89.5",
        "predisposition": "Z89.5* OTHER NONOPERATIVE CARDIAC AND VASCULAR DIAGNOSTIC PROCEDURES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 69,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1892035,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V71_",
        "predisposition": "V71 OBSERVATION AND EVALUATION FOR SUSPECTED CONDITIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 223,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 7093269,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A03",
        "predisposition": "A03* FEVER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 166,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5297227,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L08",
        "predisposition": "L08* SHOULDER SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 340,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 10873203,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L15",
        "predisposition": "L15* KNEE SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 544,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 17301315,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_T82",
        "predisposition": "T82* OBESITY (BMI >30)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 867,
        "predisposition_and_risk": 160,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5096496,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_T93",
        "predisposition": "T93* LIPID METABOLISM DISORDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.05,
        "risk_count": 811,
        "predisposition_and_risk": 74,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2035315,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_009.1",
        "predisposition": "009.1* COLITIS,ENTERITIS,GASTROENTERITIS PRESUMED INFECTIOUS ORIGIN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 84,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2326181,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_173.9",
        "predisposition": "173.9* OTHER MALIGNANT NEOPLASM OF SKIN, SITE UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 163,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4547567,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_216.9",
        "predisposition": "216.9* BENIGN NEOPLASM OF SKIN, SITE UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 149,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4791322,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_362.1",
        "predisposition": "362.1* OTHER BACKGROUND RETINOPATHY AND RETINAL VASCULAR CHANGES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 88,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2453519,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_367.1",
        "predisposition": "367.1* MYOPIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 99,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2761988,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_372.0",
        "predisposition": "372.0* ACUTE CONJUNCTIVITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 224,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 6254141,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_373.0",
        "predisposition": "373.0* BLEPHARITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 97,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2708058,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_375.1",
        "predisposition": "375.1* OTHER DISORDERS OF LACRIMAL GLAND",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 306,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 9873421,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_386.1",
        "predisposition": "386.1* OTHER AND UNSPECIFIED PERIPHERAL VERTIGO",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 49,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1362620,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_466.0",
        "predisposition": "466.0* ACUTE BRONCHITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 348,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 9721923,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_599.7",
        "predisposition": "599.7* HEMATURIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 113,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3648799,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_681.1",
        "predisposition": "681.1* CELLULITIS AND ABSCESS OF TOE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 774238,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_682.7",
        "predisposition": "682.7* CELLULITIS AND ABSCESS OF FOOT, EXCEPT TOES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 96,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2678915,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_698.9",
        "predisposition": "698.9* UNSPECIFIED PRURITIC DISORDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 80,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2570239,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_701.9",
        "predisposition": "701.9* UNSPECIFIED HYPERTROPHIC AND ATROPHIC CONDITIONS OF SKIN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 93,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2986230,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_706.8",
        "predisposition": "706.8* OTHER SPECIFIED DISEASES OF SEBACEOUS GLANDS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 48,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1537703,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_719.4",
        "predisposition": "719.4* PAIN IN JOINT",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 422,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 13613216,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_722.1",
        "predisposition": "722.1* DISPL.OF THORACIC OR LUMBAR INTERVERT.DISC WITHOUT MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 67,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2149161,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_724.0",
        "predisposition": "724.0* SPINAL STENOSIS, OTHER THAN CERVICAL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 118,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3274171,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_726.6",
        "predisposition": "726.6* ENTHESOPATHY OF KNEE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 584278,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_733.9",
        "predisposition": "733.9* OTHER AND UNSPECIFIED DISORDERS OF BONE AND CARTILAGE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 49,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1583291,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_753.1",
        "predisposition": "753.1* CONGENITAL CYSTIC KIDNEY DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 40,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1111175,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.4",
        "predisposition": "780.4* DIZZINESS AND GIDDINESS (VERTIGO)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 492,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 15813091,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_788.4",
        "predisposition": "788.4* FREQUENCY OF URINATION AND POLYURIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 74,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2390929,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_847.0",
        "predisposition": "847.0* NECK SPRAIN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 90,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2510072,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_995.2",
        "predisposition": "995.2* UNSP.ADV.EFFECT OF DRUG,MEDICINAL/BIOLOGICAL SUBSTANCE N.E.S.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 33,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 918455,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V72.6",
        "predisposition": "V72.6* LABORATORY EXAMINATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 374,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 10392920,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z45.2",
        "predisposition": "Z45.2* DIAGNOSTIC PROCEDURES ON LARGE INTESTINE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 62,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1994924,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_411_",
        "predisposition": "411 OTHER ACUTE AND SUBACUTE FORMS OF ISCHEMIC HEART DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 867,
        "predisposition_and_risk": 156,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5016508,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_708_",
        "predisposition": "708 URTICARIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 23,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 639623,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_311",
        "predisposition": "311* DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 51,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1415144,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_H02",
        "predisposition": "H02* HEARING COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.04,
        "risk_count": 811,
        "predisposition_and_risk": 84,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2341223,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_241.0",
        "predisposition": "241.0* NONTOXIC UNINODULAR GOITER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 61,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1976445,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_266.2",
        "predisposition": "266.2* OTHER B-COMPLEX DEFICIENCIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 123,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4008119,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_272.2",
        "predisposition": "272.2* MIXED HYPERLIPIDEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 712989,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_272.4",
        "predisposition": "272.4* OTHER AND UNSPECIFIED HYPERLIPIDEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 517,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 14474867,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_337.9",
        "predisposition": "337.9* UNSPECIFIED DISORDER OF AUTONOMIC NERVOUS SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 70,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2282407,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_382.3",
        "predisposition": "382.3* UNSPECIFIED CHRONIC SUPPURATIVE OTITIS MEDIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 591840,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_458.0",
        "predisposition": "458.0* ORTHOSTATIC HYPOTENSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 588774,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_506.1",
        "predisposition": "506.1* ACUTE PULMONARY EDEMA DUE TO FUMES AND VAPORS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 43,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1201870,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_721.0",
        "predisposition": "721.0* CERVICAL SPONDYLOSIS WITHOUT MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 40,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1122002,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_722.9",
        "predisposition": "722.9* OTHER AND UNSPECIFIED DISC DISORDER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 89,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2897857,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_723.1",
        "predisposition": "723.1* CERVICALGIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 422,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 13754682,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_724.5",
        "predisposition": "724.5* BACKACHE, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 356,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 11523672,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_729.2",
        "predisposition": "729.2* NEURALGIA, NEURITIS, AND RADICULITIS, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 93,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2617575,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.5",
        "predisposition": "780.5* SLEEP DISTURBANCES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 243,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 7927875,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_784.5",
        "predisposition": "784.5* OTHER SPEECH DISTURBANCE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 27,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 874902,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_790.4",
        "predisposition": "790.4* NONSPECIFIC ELEVATION OF LEVELS OF TRANSAMINASE OR LDH",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 109,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3071906,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_790.6",
        "predisposition": "790.6* OTHER ABNORMAL BLOOD CHEMISTRY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 95,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2674289,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V12.5",
        "predisposition": "V12.5* PERSONAL HISTORY OF DISEASES OF CIRCULATORY SYSTEM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 51,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1659384,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V14.8",
        "predisposition": "V14.8* PERSONAL HISTORY OF ALLERGY TO SPECIFIED MEDICINAL AGENTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 71,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1992601,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z38.1",
        "predisposition": "Z38.1* ENDARTERECTOMY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 588507,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z51.2",
        "predisposition": "Z51.2* CHOLECYSTECTOMY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 53,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1716417,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z95.0",
        "predisposition": "Z95.0* GENERAL AND SUBJECTIVE EYE EXAMINATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 51,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1649822,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_250_",
        "predisposition": "250 DIABETES MELLITUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 690,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 19425085,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_401_",
        "predisposition": "401 ESSENTIAL HYPERTENSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 697,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 22675263,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_V71_",
        "predisposition": "V71 OBSERVATION AND EVALUATION FOR SUSPECTED CONDITIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 191,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5365534,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_566",
        "predisposition": "566* ABSCESS OF ANAL AND RECTAL REGIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 26,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 733206,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A80",
        "predisposition": "A80* ACCIDENT/INJURY; NOS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 272,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 8793772,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_A97",
        "predisposition": "A97* NO DISEASE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 867,
        "predisposition_and_risk": 143,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4645654,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L08",
        "predisposition": "L08* SHOULDER SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.03,
        "risk_count": 811,
        "predisposition_and_risk": 270,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 7566166,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_079.9",
        "predisposition": "079.9* UNSP.VIRAL INFECT.IN CONDITIONS CLASSIF.ELSEWHERE,UNSP.SITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 210,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5956127,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_272.4",
        "predisposition": "272.4* OTHER AND UNSPECIFIED HYPERLIPIDEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 445,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 14591797,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_285.9",
        "predisposition": "285.9* ANEMIA, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 110,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3624415,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_362.0",
        "predisposition": "362.0* DIABETIC RETINOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 37,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1215753,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_372.4",
        "predisposition": "372.4* PTERYGIUM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 54,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1770599,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_373.0",
        "predisposition": "373.0* BLEPHARITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 124,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4079746,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_374.3",
        "predisposition": "374.3* PTOSIS OF EYELID",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 30,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 852115,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_380.4",
        "predisposition": "380.4* IMPACTED CERUMEN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 252,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 7170149,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_381.0",
        "predisposition": "381.0* ACUTE NONSUPPURATIVE OTITIS MEDIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 71,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2335234,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_466.0",
        "predisposition": "466.0* ACUTE BRONCHITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 463,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 15219162,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_524.6",
        "predisposition": "524.6* TEMPOROMANDIBULAR JOINT DISORDERS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 80,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2621306,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_692.9",
        "predisposition": "692.9* CONTACT DERMATITIS AND OTHER ECZEMA, UNSPECIFIED CAUSE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 76,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2503690,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_706.2",
        "predisposition": "706.2* SEBACEOUS CYST",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 98,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2780907,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_722.7",
        "predisposition": "722.7* INTERVERTEBRAL DISC DISORDER WITH MYELOPATHY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 25,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 705880,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.7",
        "predisposition": "780.7* MALAISE AND FATIGUE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 149,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4211832,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_785.1",
        "predisposition": "785.1* PALPITATIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 94,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2658091,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_785.1",
        "predisposition": "785.1* PALPITATIONS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 233,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 7609753,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_786.5",
        "predisposition": "786.5* CHEST PAIN",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 385,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 10924816,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_788.1",
        "predisposition": "788.1* DYSURIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 192,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 6284040,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_790.4",
        "predisposition": "790.4* NONSPECIFIC ELEVATION OF LEVELS OF TRANSAMINASE OR LDH",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 151,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 4957655,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V45.0",
        "predisposition": "V45.0* POSTSURGICAL CARDIAC PACEMAKER IN SITU",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 22,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 722120,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z37.2",
        "predisposition": "Z37.2* DIAGNOSTIC PROCEDURES ON HEART AND PERICARDIUM",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 47,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1547972,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_Z39.5",
        "predisposition": "Z39.5* OTHER REPAIR OF VESSELS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 28,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 794808,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z87.4",
        "predisposition": "Z87.4* OTHER X-RAY OF THORAX",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 84,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 2742149,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z95.4",
        "predisposition": "Z95.4* NONOPERATIVE PROCEDURES RELATED TO HEARING",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 24,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 785909,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_250_",
        "predisposition": "250 DIABETES MELLITUS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 681,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 22397634,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_401_",
        "predisposition": "401 ESSENTIAL HYPERTENSION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 676,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 19181734,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_454_",
        "predisposition": "454 VARICOSE VEINS OF LOWER EXTREMITIES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 58,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1638600,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_525_",
        "predisposition": "525 DISEASES AND CONDITIONS OF THE TEETH AND SUPPORT.STRUCTURES",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 268,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 8764498,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_532_",
        "predisposition": "532 DUODENAL ULCER",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 29,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 824723,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_600_",
        "predisposition": "600 HYPERPLASIA OF PROSTATE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 185,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5222099,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_496",
        "predisposition": "496* CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 73,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 2065473,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_L02",
        "predisposition": "L02* BACK SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 811,
        "predisposition_and_risk": 155,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4388040,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L02",
        "predisposition": "L02* BACK SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 208,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 6820801,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L10",
        "predisposition": "L10* ELBOW SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 29,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 955625,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L16",
        "predisposition": "L16* ANKLE SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.02,
        "risk_count": 867,
        "predisposition_and_risk": 92,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3009373,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_041.1",
        "predisposition": "041.1* STAPHYLOCOCCUS INFECT.IN CONDIT.CLASSIF.ELSEWHERE,UNSP.SITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 22,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 631477,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_272.0",
        "predisposition": "272.0* PURE HYPERCHOLESTEROLEMIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 417,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 13863562,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_274.9",
        "predisposition": "274.9* GOUT, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 35,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1001137,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_368.0",
        "predisposition": "368.0* AMBLYOPIA EX ANOPSIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 37,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1060359,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_428.1",
        "predisposition": "428.1* LEFT HEART FAILURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 57,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1626607,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_434.9",
        "predisposition": "434.9* CEREBRAL ARTERY OCCLUSION, UNSPECIFIED",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 49,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1409881,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_530.1",
        "predisposition": "530.1* ESOPHAGITIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 165,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4738551,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_627.1",
        "predisposition": "627.1* POSTMENOPAUSAL BLEEDING",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 58,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1923798,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_780.4",
        "predisposition": "780.4* DIZZINESS AND GIDDINESS (VERTIGO)",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 359,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 10299128,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_780.7",
        "predisposition": "780.7* MALAISE AND FATIGUE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 180,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5969049,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_782.1",
        "predisposition": "782.1* RASH AND OTHER NONSPECIFIC SKIN ERUPTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 59,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1955110,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_786.3",
        "predisposition": "786.3* HEMOPTYSIS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 28,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 924648,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_924.9",
        "predisposition": "924.9* CONTUSION OF UNSPECIFIED SITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 191,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5475423,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_P02.7",
        "predisposition": "P02.7* ISSUE OF MEDICAL CERTIFICATE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 52,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1720974,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z88.5",
        "predisposition": "Z88.5* ANGIOCARDIOGRAPHY USING CONTRAST MATERIAL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 91,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3016890,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_268_",
        "predisposition": "268 VITAMIN D DEFICIENCY",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 152,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 5055306,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_410_",
        "predisposition": "410 ACUTE MYOCARDIAL INFARCTION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 183,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5248584,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_455_",
        "predisposition": "455 HEMORRHOIDS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 103,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3411759,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_493_",
        "predisposition": "493 ASTHMA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 168,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4809175,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_V67_",
        "predisposition": "V67 FOLLOW-UP EXAMINATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 350,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 11594615,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_431",
        "predisposition": "431* INTRACEREBRAL HEMORRHAGE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 811,
        "predisposition_and_risk": 38,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1091655,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_L04",
        "predisposition": "L04* CHEST SYMPTOMS/COMPLAINTS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1.01,
        "risk_count": 867,
        "predisposition_and_risk": 362,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 11968889,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_110.1",
        "predisposition": "110.1* DERMATOPHYTOSIS OF NAIL",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 811,
        "predisposition_and_risk": 206,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 5932504,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_354.2",
        "predisposition": "354.2* LESION OF ULNAR NERVE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 811,
        "predisposition_and_risk": 21,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 607078,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_386.1",
        "predisposition": "386.1* OTHER AND UNSPECIFIED PERIPHERAL VERTIGO",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 867,
        "predisposition_and_risk": 91,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 3031225,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_564.0",
        "predisposition": "564.0* CONSTIPATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 867,
        "predisposition_and_risk": 202,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 6741915,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_782.3",
        "predisposition": "782.3* EDEMA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 811,
        "predisposition_and_risk": 46,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1325674,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_791.0",
        "predisposition": "791.0* PROTEINURIA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 811,
        "predisposition_and_risk": 142,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 4094025,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_959.9",
        "predisposition": "959.9* OTHER AND UNSPECIFIED INJURY TO UNSPECIFIED SITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 811,
        "predisposition_and_risk": 136,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 3923702,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_Z89.2",
        "predisposition": "Z89.2* ANATOM.-PHYSIOL.MEASUREMENTS+MANUAL EXAM.GENITOURINARY SYST.",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 867,
        "predisposition_and_risk": 251,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 8394730,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_278_",
        "predisposition": "278 OBESITY AND OTHER HYPERALIMENTATION",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 867,
        "predisposition_and_risk": 30,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 998769,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_365_",
        "predisposition": "365 GLAUCOMA",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 867,
        "predisposition_and_risk": 185,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 6179405,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "male",
        "track": "icd9_584_",
        "predisposition": "584 ACUTE RENAL FAILURE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 811,
        "predisposition_and_risk": 60,
        "risk_duration": 23451865,
        "predisposition_and_risk_duration": 1733458,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_715_",
        "predisposition": "715 OSTEOARTHROSIS AND ALLIED DISORDERS",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 867,
        "predisposition_and_risk": 281,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 9357832,
        "type": "ICD9"
      },
      {
        "age_group": "[60,70)",
        "gender": "female",
        "track": "icd9_S12",
        "predisposition": "S12* INSECT BITE",
        "risk": "cohort.5Fc.5F4e119a7b3d6488e8bfae3b8a184279f2",
        "rr": 1,
        "risk_count": 867,
        "predisposition_and_risk": 41,
        "risk_duration": 29002769,
        "predisposition_and_risk_duration": 1368745,
        "type": "ICD9"
      }
    ],
    "figures": null,
    "messageType": "chronicDiseaseCohorts.report",
    "requestId": "52098f8e-07cb-4fb3-a36c-39179d130a6b",
    "cohortId": "c_4e119a7b3d6488e8bfae3b8a184279f2"
  },
  "id": "52098f8e-07cb-4fb3-a36c-39179d130a6b"
}